Here you will find key facts about our supply chain orchestration platform Hypertrust X-Chain. We have summarized the most important information for you in a poster. You can download it here for free.
Read the thoughts of our CEO Andreas Göbel and our Head of Business Development Dr. Camila Mendes on “Cell and Gene Therapy Orchestration: Real-time Supply Chain Management”. In this article, they highlight the potential of cell and gene therapy orchestration software for personalized and novel therapies. They outline the critical features and key considerations for an orchestration platform and describe the stage in the product lifecycle where each phase begins to deliver its full value.
In the video, created in collaboration with Bioinsights, our Managing Director Andreas Göbel and Head of Business Development Dr. Camila Mendes share insightful details about Hypertrust and orchestration platforms, especially the Hypertrust X-Chain platform.
Hypertrust is a young and agile company founded in 2018. Hypertrust is part of Elixum, a Camelot Group Company. As a spin-off of Camelot Group, we leverage 30 years of expertise in supply chain consulting in the pharmaceutical industry.
This exceptional mix of experience and innovation has resulted in Hypertrust X-Chain, the world’s first end-to-end supply chain management solution for ATMPs (Advanced Therapy Medicinal Products).
With our broad supplier and service provider ecosystem, we enable companies to accelerate the setup of their ATMP supply chain processes.
In the video, created in collaboration with Bioinsights, our Managing Director Andreas Göbel and Head of Business Development Dr. Camila Mendes share insightful details about Hypertrust and orchestration platforms, especially the Hypertrust X-Chain platform.
Just drop us a line
© 2025 Hypertrust Patient Data Care, Part of Accenture
